|1.||Fan, Jie: 1 article (01/2015)|
|2.||Zeng, Min: 1 article (01/2015)|
|3.||Fu, Bingmei M: 1 article (01/2015)|
|4.||Yang, Jinlin: 1 article (01/2015)|
|5.||Cai, Bin: 1 article (01/2015)|
|6.||Zhang, Lin: 1 article (01/2015)|
|7.||Aramadhaka, Lavakumar Reddy: 1 article (10/2012)|
|8.||Jansson, Kyle: 1 article (10/2012)|
|9.||Bello-Reuss, Elsa: 1 article (10/2012)|
|10.||Calvet, James P: 1 article (10/2012)|
|1.||Neuralgia (Stump Neuralgia)
|2.||Ovarian Neoplasms (Ovarian Cancer)
02/01/2002 - "HEY cells, an ovarian cancer cell line which expresses c-KIT and KL, were treated with dibutyryl cyclic AMP (dbcAMP), 8-bromo-cAMP, and cholera toxin over a range of concentrations. "
01/01/2003 - "In the present study, expression and regulation of hCG receptor mRNA were analyzed in four established human ovarian cancer cell lines using different concentrations of hCG, EGF, and 8-bromo-cAMP for different periods between 6 and 72 h. "
03/01/1996 - "Furthermore, stimulation of these cells with 56 mM KCl or with 5 mM 8-bromo-cAMP increased the release of BDNF approximately 10-to 15-fold within 30 min. To study BDNF release from primary cultures of hippocampal neurons, cells were infected with a defective Herpes Simplex Viral (HSV) vector expressing human BDNF. "
09/01/1995 - "Since these changes were relatively slow to develop and persisted with prolonged exposure to 8-bromo-cAMP, it is possible that the junctional permeability of these mammary tumor cells is linked to the 'basal' level of cAMP, i.e. "
07/15/1990 - "When transfected into mouse Y1 adrenocortical tumor cells, 1.5 kilobase pairs of 5'-flanking region of the SCC gene directed high levels of expression of a growth hormone reporter gene; treatment of the transfected Y1 cells with 8-bromo-cAMP increased this expression by 5-fold. "
01/01/2015 - "To test the hypothesis that inhibiting permeability increase can reduce tumor cell adhesion, we used in vivo fluorescence microscopy to measure both microvessel permeability and adhesion rates of human mammary carcinoma MDA-MB-231 cells in post-capillary venules of rat mesentery under the treatment of VEGF and a cAMP analog, 8-bromo-cAMP, which can decrease microvessel permeability. "
09/15/2004 - "Unfortunately substances elevating cAMP such as forskolin, 8-bromo-cAMP, 8-chloro-cAMP, monobutiryl or dibutiryl cAMP are not recommended to be used as anti-cancer drugs because of their high cytotoxicity. "
12/01/1994 - "The effects of PACAP38 were less potent than either GHRH on GH release in the somatotrope tumor or CRH on ACTH release in the corticotrope tumors but similar to the responses seen with the cAMP analog 8-bromo-cAMP (8-Br-cAMP). "
04/01/1990 - "JEG-3 human choriocarcinoma cells exhibited similar morphologic and degradative properties on Matribeach, but zone 2 proteolysis was not affected by 8-bromo-cAMP. "
12/01/1988 - "CG beta CAT was expressed preferentially in JEG-3 choriocarcinoma cells, and expression was markedly stimulated by treatment with 8-bromo-cAMP. "
06/01/1996 - "Previously we have shown that long-term pretreatment of JEG-3 choriocarcinoma cells with 8-bromo-cAMP increases the capacity for N-glycosylation that was caused by an 8-10-fold enlargement of the dolichol pyrophosphoryl oligosaccharide (Dol-PP-oligosaccharide) pool [Konrad and Merz (1994) J. "
03/25/1994 - "The influence of 8-bromo-cAMP on N-glycosylation in JEG-3 choriocarcinoma cells was investigated using the octanoyl-tripeptide (OTP; N-octanoyl-asparagyl-125I-tyrosyl-threonine amide) as glycosyl acceptor. "
10/15/1985 - "Differential regulation of hCG alpha and beta subunit mRNAs in JEG-3 choriocarcinoma cells by 8-bromo-cAMP."
|1.||Type 2 Parathyroid Hormone Receptor
|2.||Messenger RNA (mRNA)
|3.||Brain-Derived Neurotrophic Factor (BDNF)
|4.||LH Receptors (LH Receptor)
|5.||Epidermal Growth Factor (EGF)
|9.||Adenylate Cyclase (Adenylyl Cyclase)